Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03181308
Title Study of Carotuximab (TRC105) Plus Nivolumab in Patients With Metastatic NSCLC
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Tracon Pharmaceuticals Inc.
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST